EMEA-003420-PIP01-23

Tackling vulnerabilities in the supply chain of radiopharmaceuticals in the EU

Recommendations of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) to address vulnerabilities in the supply chain of radiopharmaceuticals

Human medicines European public assessment report (EPAR): Skojoy, aflibercept, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Vydura, rimegepant, Date of authorisation: 25/04/2022, Revision: 7, Status: Authorised

EMEA-003423-PIP02-23

PhV non-compliance notification contact points at National Competent Authority (NCA) level

Contacts at the European Medicines Agency

CHMP-CAT - D80-210 Overview to final EPAR - Rev 04.25 (Revamp)

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 25, Status: Authorised